Marshall University
An Open Label Study of the Effects of Levetiracetam in Children with Autism
Abstract
dc:description.abstractThis was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student's correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design.
Degree
thesis:*- Name thesis:degree_name
- Psychology
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- College of Liberal Arts
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Samsock, Teresa C.
- Contributors dc:contributor
-
- Marianna Footo-Linz
- Stephen P. Mewalett
Subjects
dc:subject × 6Identifiers
dc:identifier.*- Repository record dc:identifier
- https://mds.marshall.edu/etd/2076